Eyenovia Inc (EYEN)
0.1019
-0.24
(-70.04%)
USD |
NASDAQ |
Nov 15, 16:00
0.102
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Profit Margin (Quarterly): -48.86K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -48.86K% |
| March 31, 2024 | -218.7K% |
| December 31, 2023 | -307.7K% |
| September 30, 2023 | -612.6K% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 |
| Date | Value |
|---|---|
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 29.83% |
| September 30, 2021 | |
| June 30, 2021 | -242.1% |
| March 31, 2021 | -267.6% |
| December 31, 2020 | -210.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-612.6K%
Minimum
Sep 2023
29.83%
Maximum
Dec 2021
-148.6K%
Average
-24.56K%
Median
Profit Margin (Quarterly) Benchmarks
| TFF Pharmaceuticals Inc | -688.9% |
| Reviva Pharmaceuticals Holdings Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -536.4% |
| Return on Assets | -134.9% |
| Return on Invested Capital | -175.4% |
| Gross Profit Margin (Quarterly) | -2.07K% |
| Operating Margin (Quarterly) | -51.66K% |
| Return on Net Operating Assets | -305.9% |